Healthcare Services Group (HCSG) Financials

$22.99 -0.07 (-0.30%)

As of 10:13 AM Eastern

Annual Income Statements for Healthcare Services Group

This table shows Healthcare Services Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	58	77	88	84	65	99	47	27	40	39	61
Consolidated Net Income / (Loss)	58	77	88	84	65	99	49	34	38	39	59
Net Income / (Loss) Continuing Operations	58	77	88	84	65	99	49	34	38	39	59
Total Pre-Tax Income	90	120	133	100	85	129	66	45	53	53	68
Total Operating Income	89	118	124	98	78	117	57	53	48	45	49
Total Gross Profit	201	223	251	234	228	268	231	193	215	228	239
Total Revenue	1,437	1,563	1,861	2,003	1,841	1,760	1,642	1,690	1,671	1,716	1,837
Operating Revenue	1,437	1,563	1,861	2,003	1,841	1,760	1,642	1,690	1,671	1,716	1,837
Total Cost of Revenue	1,236	1,339	1,611	1,768	1,613	1,492	1,411	1,497	1,457	1,488	1,598
Operating Cost of Revenue	1,236	1,339	1,611	1,768	1,613	1,492	1,411	1,497	1,457	1,488	1,598
Total Operating Expenses	112	105	127	137	150	151	173	140	167	183	191
Selling, General & Admin Expense	112	105	127	137	150	151	173	140	167	183	191
Total Other Income / (Expense), net	0.71	2.63	9.08	2.07	7.22	12	8.05	-8.41	5.08	7.91	19
Interest & Investment Income	0.71	2.63	10	2.07	7.22	12	8.05	-8.41	5.08	7.91	19
Income Tax Expense	32	43	45	16	21	31	17	10	15	13	8.81
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-	-	-	-	-	-	1.56	7.48	-1.63	0.47	-1.87
Basic Earnings per Share	$0.81	$1.06	$1.20	$1.13	$0.87	$1.32	$0.65	$0.46	$0.52	$0.54	$0.82
Weighted Average Basic Shares Outstanding	71.83M	72.75M	73.36M	74.00M	74.36M	74.70M	74.82M	74.34M	74.29M	73.75M	72.38M
Diluted Earnings per Share	$0.80	$1.05	$1.19	$1.12	$0.87	$1.32	$0.65	$0.46	$0.52	$0.53	$0.81
Weighted Average Diluted Shares Outstanding	72.51M	73.47M	74.35M	74.61M	74.59M	74.79M	74.96M	74.35M	74.34M	73.99M	73.03M
Weighted Average Basic & Diluted Shares Outstanding	71.60M	73M	73.50M	73.90M	74.40M	74.72M	74.00M	74.39M	73.58M	73.49M	70.27M

This table shows Healthcare Services Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-6.69	26	15	-2.23	16	10	18	-32	44	32	26
Consolidated Net Income / (Loss)	-5.05	24	15	-1.79	14	12	17	-32	43	31	26
Net Income / (Loss) Continuing Operations	-5.05	24	15	-1.79	14	12	17	-32	43	31	26
Total Pre-Tax Income	-6.33	32	21	-1.99	19	15	24	-42	57	29	35
Total Operating Income	-4.60	28	18	-2.89	17	14	23	-46	46	26	34
Total Gross Profit	34	75	65	42	63	59	68	2.96	96	72	76
Total Revenue	411	424	423	426	428	438	448	458	464	467	463
Operating Revenue	411	424	423	426	428	438	448	458	464	467	463
Total Cost of Revenue	377	349	359	385	365	379	380	456	368	395	387
Operating Cost of Revenue	377	349	359	385	365	379	380	456	368	395	387
Total Operating Expenses	39	46	47	44	47	45	45	49	51	46	42
Selling, General & Admin Expense	39	46	47	44	47	45	45	49	51	46	42
Total Other Income / (Expense), net	-1.74	3.83	3.70	0.91	2.28	1.03	0.89	4.32	11	2.68	0.70
Interest & Investment Income	-1.74	3.83	3.70	0.91	2.28	1.03	0.89	4.32	11	2.68	0.70
Income Tax Expense	-1.29	8.79	6.01	-0.20	4.78	2.89	6.67	-9.52	14	-2.69	8.48
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	1.65	-2.93	0.33	0.45	-2.09	1.79	-0.50	-0.37	-0.71	-0.28	0.39
Basic Earnings per Share	($0.07)	$0.32	$0.21	($0.02)	$0.19	$0.16	$0.23	($0.44)	$0.59	$0.44	$0.37
Weighted Average Basic Shares Outstanding	74.36M	74.29M	73.93M	73.85M	73.69M	73.75M	73.67M	73.16M	72.24M	72.38M	69.86M
Diluted Earnings per Share	($0.07)	$0.32	$0.21	($0.02)	$0.19	$0.15	$0.23	($0.44)	$0.59	$0.43	$0.37
Weighted Average Diluted Shares Outstanding	74.36M	74.34M	74.06M	73.85M	73.93M	73.99M	73.96M	73.16M	72.97M	73.03M	71.05M
Weighted Average Basic & Diluted Shares Outstanding	73.85M	73.58M	73.65M	73.38M	73.29M	73.49M	72.92M	72.41M	70.46M	70.27M	68.65M

This table details how cash moves in and out of Healthcare Services Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-42	-9.34	-14	16	1.30	112	-69	-45	28	5.80	71
Net Cash From Operating Activities	63	41	7.63	80	94	217	37	-8.17	43	31	145
Net Cash From Continuing Operating Activities	63	41	7.63	80	94	217	37	-8.17	43	31	145
Net Income / (Loss) Continuing Operations	58	77	88	84	65	99	49	34	38	39	59
Consolidated Net Income / (Loss)	58	77	88	84	65	99	49	34	38	39	59
Depreciation Expense	7.66	7.50	8.89	9.27	14	14	15	15	14	15	17
Amortization Expense	0.68	1.72	1.30	1.37	1.43	1.82	2.28	2.22	2.14	1.50	0.30
Non-Cash Adjustments To Reconcile Net Income	6.03	5.90	12	59	25	9.45	14	52	39	49	91
Changes in Operating Assets and Liabilities, net	-9.03	-51	-103	-73	-11	93	-43	-112	-50	-74	-22
Net Cash From Investing Activities	-62	-6.45	-15	-9.59	-16	-37	-23	2.58	-3.29	6.05	-11
Net Cash From Continuing Investing Activities	-62	-6.45	-15	-9.59	-16	-37	-23	2.58	-3.29	6.05	-11
Purchase of Property, Plant & Equipment	-5.00	-5.44	-5.40	-4.94	-4.37	-4.34	-5.69	-5.21	-5.41	-6.34	-5.82
Acquisitions	0.00	0.00	-4.58	-	0.00	0.00	-24	-0.11	0.00	-2.75	-9.78
Purchase of Investments	-75	-29	-34	-14	-34	-39	-20	-2.88	0.00	-52	-19
Sale of Property, Plant & Equipment	0.27	0.28	0.34	0.64	0.20	0.27	0.21	0.39	0.12	0.21	0.11
Sale and/or Maturity of Investments	18	28	29	9.01	21	6.27	27	10	1.99	67	23
Net Cash From Financing Activities	-43	-44	-6.96	-54	-76	-68	-83	-39	-12	-31	-63
Net Cash From Continuing Financing Activities	-43	-44	-6.96	-54	-76	-68	-83	-39	-12	-31	-63
Repayment of Debt	-	0.00	-	-5.38	-20	-10	0.00	25	0.00	-25	0.00
Repurchase of Common Equity	-	-	-	-0.28	-0.59	-0.68	-23	-1.07	-11	-5.02	-62
Other Financing Activities, net	8.12	8.95	13	8.80	3.63	2.92	2.43	0.41	-0.87	-1.03	-1.74
Cash Interest Paid	0.26	0.57	1.36	3.09	3.46	1.37	1.39	2.82	7.81	6.49	1.68

This table details how cash moves in and out of Healthcare Services Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	2.65	23	-0.35	-24	-1.41	32	4.25	19	41	6.35	5.50
Net Cash From Operating Activities	2.94	49	-26	16	4.31	36	28	29	71	17	44
Net Cash From Continuing Operating Activities	2.94	49	-26	16	4.31	36	28	29	71	17	44
Net Income / (Loss) Continuing Operations	-5.05	24	15	-1.79	14	12	17	-32	43	31	26
Consolidated Net Income / (Loss)	-5.05	24	15	-1.79	14	12	17	-32	43	31	26
Depreciation Expense	3.25	3.78	3.53	3.68	3.77	3.60	3.88	5.00	4.03	3.87	3.81
Amortization Expense	0.54	0.54	0.46	0.34	0.21	0.50	0.12	0.12	0.12	-0.06	0.05
Non-Cash Adjustments To Reconcile Net Income	18	1.70	3.48	33	0.31	12	6.34	68	9.36	6.96	8.22
Changes in Operating Assets and Liabilities, net	-14	20	-49	-19	-14	7.81	-0.07	-12	15	-25	5.59
Net Cash From Investing Activities	-1.27	-1.38	12	-28	0.29	22	-14	-2.35	-2.75	8.56	-12
Net Cash From Continuing Investing Activities	-1.27	-1.38	12	-28	0.29	22	-14	-2.35	-2.75	8.56	-12
Purchase of Property, Plant & Equipment	-1.88	-1.43	-2.20	-1.31	-1.40	-1.43	-1.74	-1.36	-1.34	-1.38	-1.40
Acquisitions	-	-	-2.75	-	-	-	-9.41	-	-	-0.37	-4.58
Purchase of Investments	-	-	0.00	-	-14	-0.60	-3.44	-1.18	-9.27	-4.83	-7.31
Sale of Property, Plant & Equipment	0.04	-	0.03	0.13	0.04	0.02	0.03	0.05	0.01	0.02	0.06
Sale and/or Maturity of Investments	0.57	0.05	17	11	15	24	0.10	0.13	7.85	15	1.68
Net Cash From Financing Activities	0.98	-25	14	-13	-6.01	-26	-8.78	-7.68	-27	-20	-27
Net Cash From Continuing Financing Activities	0.98	-25	14	-13	-6.01	-26	-8.78	-7.68	-27	-20	-27
Repurchase of Common Equity	-4.02	-5.05	-1.03	-3.00	-1.01	-1.01	-8.78	-7.68	-27	-18	-28
Other Financing Activities, net	-	-	-	-	-	-	0.00	-	-	-	1.45

This table presents Healthcare Services Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	481	528	676	693	723	785	778	721	791	803	794
Total Current Assets	365	415	527	508	516	572	546	509	572	557	576
Cash & Equivalents	33	24	9.56	26	27	139	71	26	54	57	125
Restricted Cash	-	-	-	-	-	-	-	-	0.00	28	36
Short-Term Investments	69	68	73	76	91	125	114	95	93	51	43
Note & Lease Receivable	215	271	379	342	341	255	293	337	39	51	31
Accounts Receivable	-	-	-	-	-	-	-	-	345	331	281
Inventories, net	36	38	42	41	37	32	26	21	18	17	17
Prepaid Expenses	11	14	24	22	20	21	33	23	22	22	21
Current Deferred & Refundable Income Taxes	-	-	-	-	-	0.39	8.81	6.63	-	0.00	22
Plant, Property, & Equipment, net	13	13	14	13	0.00	0.00	28	23	29	28	28
Total Noncurrent Assets	103	100	135	172	207	213	203	189	190	218	190
Noncurrent Note & Lease Receivables	2.97	7.53	15	43	47	34	29	33	25	41	25
Goodwill	44	44	51	51	51	51	75	76	76	76	80
Intangible Assets	17	14	31	27	22	18	21	16	12	9.44	6.96
Noncurrent Deferred & Refundable Income Taxes	13	9.82	7.50	21	20	36	32	31	35	38	18
Employee Benefit Assets	25	24	29	29	37	47	47	33	41	50	56
Other Noncurrent Operating Assets	0.05	0.05	1.26	1.26	29	27	0.00	0.81	1.66	4.09	3.90
Total Liabilities & Shareholders' Equity	481	528	676	693	723	785	778	721	791	803	794
Total Liabilities	184	190	276	252	262	305	325	303	334	303	284
Total Current Liabilities	96	101	184	163	149	162	191	189	217	193	170
Accounts Payable	41	43	74	61	54	52	64	68	83	81	77
Accrued Expenses	14	4.40	4.56	8.89	16	18	27	18	21	26	37
Current Employee Benefit Liabilities	38	46	54	35	36	71	76	55	58	52	31
Other Current Liabilities	-	0.00	35	51	33	22	24	23	23	25	24
Total Noncurrent Liabilities	88	89	92	88	114	142	134	114	117	110	114
Capital Lease Obligations	-	-	-	-	-	11	11	8.10	11	8.03	9.66
Noncurrent Employee Benefit Liabilities	88	89	92	30	102	131	112	99	103	102	102
Other Noncurrent Operating Liabilities	-	-	-	-	12	0.00	10	6.14	2.99	0.39	1.59
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	296	339	400	441	460	480	453	418	457	500	510
Total Preferred & Common Equity	296	339	400	441	460	480	453	418	457	500	510
Total Common Equity	296	339	400	441	460	480	453	418	457	500	510
Common Stock	200	218	245	260	271	283	295	303	311	319	329
Retained Earnings	107	131	164	190	195	201	184	147	185	225	284
Treasury Stock	-11	-10	-9.86	-9.66	-9.44	-8.96	-30	-28	-38	-41	-102
Accumulated Other Comprehensive Income / (Loss)	0.54	-0.32	0.84	0.16	2.92	5.56	4.00	-3.48	-1.84	-2.32	-0.45

This table presents Healthcare Services Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	722	719	762	751	804	800	806	823	802	804	815
Total Current Assets	513	510	549	533	580	573	578	575	532	581	601
Cash & Equivalents	20	16	29	31	29	26	27	64	83	124	136
Restricted Cash	-	-	-	-	25	25	26	29	30	30	36
Short-Term Investments	94	96	93	90	76	79	77	50	52	53	42
Note & Lease Receivable	347	351	380	368	407	399	406	49	32	25	29
Accounts Receivable	-	-	-	-	-	-	-	338	292	289	299
Inventories, net	23	20	20	19	18	18	17	17	17	17	16
Prepaid Expenses	24	25	26	24	26	26	25	27	27	26	28
Current Deferred & Refundable Income Taxes	5.43	1.75	0.93	1.17	-	-	-	-	-	16	14
Plant, Property, & Equipment, net	24	23	27	29	29	30	28	29	28	27	27
Total Noncurrent Assets	185	186	186	188	194	197	199	219	242	197	187
Noncurrent Note & Lease Receivables	27	32	31	29	23	21	23	36	45	28	21
Goodwill	76	76	76	76	76	76	76	80	80	80	80
Intangible Assets	17	15	14	13	11	11	10	10	8.26	7.61	6.32
Noncurrent Deferred & Refundable Income Taxes	34	28	28	33	35	39	36	40	53	22	18
Employee Benefit Assets	32	34	37	36	44	46	49	47	52	55	53
Other Noncurrent Operating Assets	-	0.76	0.71	1.81	4.30	4.51	5.61	6.09	3.64	3.52	8.88
Total Liabilities & Shareholders' Equity	722	719	762	751	804	800	806	823	802	804	815
Total Liabilities	300	279	311	309	329	328	317	309	325	308	301
Total Current Liabilities	182	162	190	188	209	209	197	199	214	196	193
Accounts Payable	67	64	66	71	73	72	77	79	78	82	83
Accrued Expenses	16	17	17	20	22	23	26	37	42	38	38
Current Employee Benefit Liabilities	47	22	41	26	40	58	44	48	68	53	50
Other Current Liabilities	26	24	25	25	23	22	22	26	25	24	22
Total Noncurrent Liabilities	118	116	122	121	120	119	120	110	111	113	108
Capital Lease Obligations	8.75	8.59	12	12	11	11	9.03	7.95	7.05	6.22	9.36
Noncurrent Employee Benefit Liabilities	102	101	106	106	107	107	110	100	103	105	97
Other Noncurrent Operating Liabilities	8.00	6.45	3.85	3.12	2.27	0.72	0.43	2.04	1.65	1.65	1.59
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	422	441	451	442	475	471	489	514	477	496	514
Total Preferred & Common Equity	422	441	451	442	475	471	489	514	477	496	514
Total Common Equity	422	441	451	442	475	471	489	514	477	496	514
Common Stock	301	304	307	309	313	315	317	321	324	326	330
Retained Earnings	155	167	176	170	200	199	213	242	209	252	310
Treasury Stock	-28	-29	-29	-33	-36	-39	-40	-47	-55	-82	-125
Accumulated Other Comprehensive Income / (Loss)	-5.51	-2.27	-3.13	-4.78	-2.17	-2.62	-0.52	-1.81	-1.44	-0.73	-0.84

This table displays calculated financial ratios and metrics derived from Healthcare Services Group's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	11.11%	8.76%	19.10%	7.60%	-8.08%	-4.37%	-6.72%	2.94%	-1.11%	2.65%	7.08%
EBITDA Growth	158.32%	30.37%	5.59%	-19.08%	-14.04%	42.94%	-44.19%	-5.24%	-8.57%	-5.19%	7.35%
EBIT Growth	196.05%	32.23%	5.21%	-21.03%	-20.40%	50.50%	-50.98%	-7.82%	-9.43%	-6.14%	7.79%
NOPAT Growth	177.71%	31.51%	8.58%	-0.50%	-27.74%	51.48%	-52.45%	-4.38%	-14.74%	-3.27%	25.82%
Net Income Growth	165.56%	33.39%	13.99%	-5.33%	-22.68%	52.80%	-50.81%	-29.46%	12.10%	2.83%	49.63%
EPS Growth	158.06%	31.25%	13.33%	-5.88%	-22.32%	51.72%	-50.76%	-29.23%	13.04%	1.92%	52.83%
Operating Cash Flow Growth	9.75%	-34.66%	-81.57%	948.90%	16.93%	132.11%	-82.92%	-122.01%	632.61%	-29.19%	370.64%
Free Cash Flow Firm Growth	26.55%	-57.72%	-44.70%	393.03%	-8.81%	269.92%	-104.27%	-19.16%	284.75%	-64.75%	1,353.42%
Invested Capital Growth	2.66%	27.60%	28.28%	6.69%	1.14%	-33.54%	22.55%	18.33%	4.70%	7.76%	-15.10%
Revenue Q/Q Growth	1.73%	2.12%	5.43%	0.02%	-2.54%	-1.33%	-0.17%	0.21%	-0.01%	0.82%	1.60%
EBITDA Q/Q Growth	-9.66%	18.93%	0.04%	8.16%	-12.93%	4.37%	-25.96%	26.12%	21.31%	-19.60%	21.93%
EBIT Q/Q Growth	-10.74%	20.49%	-0.26%	9.49%	-16.32%	5.03%	-31.48%	37.84%	30.85%	-24.60%	33.19%
NOPAT Q/Q Growth	-10.64%	18.80%	-3.50%	26.31%	-22.52%	7.35%	-32.55%	38.49%	24.43%	-22.45%	57.87%
Net Income Q/Q Growth	-9.85%	16.86%	-0.13%	15.75%	-16.39%	9.85%	-32.11%	47.24%	25.24%	-22.70%	48.63%
EPS Q/Q Growth	-11.11%	16.67%	1.71%	14.29%	-15.53%	9.09%	-32.29%	53.33%	23.81%	-24.29%	52.83%
Operating Cash Flow Q/Q Growth	-26.82%	-15.08%	15.19%	1.28%	9.14%	40.22%	-54.41%	-2,676.34%	156.69%	-30.06%	-11.49%
Free Cash Flow Firm Q/Q Growth	-29.94%	-28.62%	442.35%	37.23%	-6.88%	29.62%	-114.43%	72.63%	385.83%	-75.43%	-21.13%
Invested Capital Q/Q Growth	0.11%	9.33%	2.62%	2.64%	-1.27%	-16.50%	1.36%	-3.66%	-8.40%	-5.24%	7.22%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	13.97%	14.28%	13.47%	11.71%	12.38%	15.22%	14.04%	11.44%	12.85%	13.29%	13.03%
EBITDA Margin	6.78%	8.13%	7.20%	5.42%	5.07%	7.57%	4.53%	4.17%	3.86%	3.56%	3.57%
Operating Margin	6.20%	7.54%	6.66%	4.89%	4.23%	6.66%	3.50%	3.13%	2.87%	2.62%	2.64%
EBIT Margin	6.20%	7.54%	6.66%	4.89%	4.23%	6.66%	3.50%	3.13%	2.87%	2.62%	2.64%
Profit (Net Income) Margin	4.04%	4.95%	4.74%	4.17%	3.51%	5.61%	2.96%	2.03%	2.30%	2.30%	3.21%
Tax Burden Percent	64.64%	64.29%	66.35%	83.60%	75.89%	76.39%	74.10%	76.86%	72.35%	74.56%	87.02%
Interest Burden Percent	100.80%	102.24%	107.33%	102.12%	109.27%	110.22%	114.02%	84.11%	110.59%	117.57%	139.82%
Effective Tax Rate	35.36%	35.71%	33.65%	16.40%	24.11%	23.61%	25.90%	23.14%	27.65%	25.44%	12.98%
Return on Invested Capital (ROIC)	30.10%	34.33%	29.13%	24.95%	17.37%	31.43%	16.82%	13.38%	10.28%	9.36%	12.28%
ROIC Less NNEP Spread (ROIC-NNEP)	29.61%	32.59%	22.22%	23.08%	12.40%	26.50%	14.02%	18.31%	6.60%	4.42%	1.83%
Return on Net Nonoperating Assets (RNNOA)	-9.82%	-9.96%	-5.24%	-5.08%	-3.03%	-10.45%	-6.42%	-5.51%	-1.50%	-1.10%	-0.58%
Return on Equity (ROE)	20.28%	24.37%	23.88%	19.87%	14.33%	20.98%	10.40%	7.86%	8.78%	8.25%	11.69%
Cash Return on Invested Capital (CROIC)	27.47%	10.07%	4.35%	18.48%	16.23%	71.72%	-3.45%	-3.42%	5.69%	1.89%	28.61%
Operating Return on Assets (OROA)	18.74%	23.33%	20.57%	14.30%	11.01%	15.55%	7.35%	7.07%	6.35%	5.65%	6.08%
Return on Assets (ROA)	12.21%	15.34%	14.65%	12.21%	9.13%	13.09%	6.21%	4.57%	5.08%	4.95%	7.40%
Return on Common Equity (ROCE)	20.28%	24.37%	23.88%	19.87%	14.33%	20.98%	10.40%	7.86%	8.78%	8.25%	11.69%
Return on Equity Simple (ROE_SIMPLE)	19.57%	22.84%	22.06%	18.95%	14.03%	20.54%	10.72%	8.19%	8.41%	7.90%	0.00%
Net Operating Profit after Tax (NOPAT)	58	76	82	82	59	90	43	41	35	34	42
NOPAT Margin	4.01%	4.84%	4.42%	4.08%	3.21%	5.09%	2.59%	2.41%	2.08%	1.96%	2.30%
Net Nonoperating Expense Percent (NNEP)	0.49%	1.74%	6.91%	1.87%	4.97%	4.93%	2.80%	-4.93%	3.68%	4.94%	10.45%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	9.02%	7.04%	6.61%	8.13%
Cost of Revenue to Revenue	86.03%	85.72%	86.53%	88.29%	87.62%	84.78%	85.96%	88.56%	87.15%	86.71%	86.97%
SG&A Expenses to Revenue	7.77%	6.75%	6.81%	6.82%	8.15%	8.57%	10.54%	8.30%	9.98%	10.67%	10.39%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	7.77%	6.75%	6.81%	6.82%	8.15%	8.57%	10.54%	8.30%	9.98%	10.67%	10.39%
Earnings before Interest and Taxes (EBIT)	89	118	124	98	78	117	57	53	48	45	49
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	97	127	134	108	93	133	74	71	64	61	66
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.90	6.97	8.16	5.78	3.46	3.98	2.77	2.13	1.68	1.70	2.64
Price to Tangible Book Value (P/TBV)	8.70	8.44	10.26	7.02	4.12	4.65	3.51	2.72	2.08	2.05	3.18
Price to Revenue (P/Rev)	1.42	1.51	1.75	1.27	0.87	1.09	0.76	0.53	0.46	0.50	0.73
Price to Earnings (P/E)	35.24	30.53	36.97	30.53	24.68	19.39	26.69	33.22	19.14	21.83	22.11
Dividend Yield	2.51%	2.25%	1.69%	2.24%	3.69%	3.16%	4.95%	7.11%	0.00%	0.00%	0.00%
Earnings Yield	2.84%	3.28%	2.70%	3.28%	4.05%	5.16%	3.75%	3.01%	5.23%	4.58%	4.52%
Enterprise Value to Invested Capital (EV/IC)	10.02	9.19	10.02	7.23	4.31	7.30	3.87	2.43	1.90	1.94	3.65
Enterprise Value to Revenue (EV/Rev)	1.35	1.45	1.71	1.22	0.80	0.94	0.66	0.47	0.39	0.42	0.63
Enterprise Value to EBITDA (EV/EBITDA)	19.94	17.89	23.72	22.56	15.83	12.45	14.51	11.36	10.15	11.84	17.57
Enterprise Value to EBIT (EV/EBIT)	21.81	19.29	25.66	25.02	18.95	14.16	18.79	15.12	13.64	16.07	23.75
Enterprise Value to NOPAT (EV/NOPAT)	33.74	30.00	38.68	29.92	24.97	18.54	25.36	19.67	18.86	21.55	27.29
Enterprise Value to Operating Cash Flow (EV/OCF)	30.65	54.86	416.70	30.58	15.77	7.64	29.10	0.00	15.05	23.49	7.95
Enterprise Value to Free Cash Flow (EV/FCFF)	36.96	102.24	258.79	40.41	26.72	8.12	0.00	0.00	34.06	106.81	11.71
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.02	0.03	0.08	0.08	0.02	0.02
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.02	0.03	0.02	0.02	0.02	0.02
Financial Leverage	-0.33	-0.31	-0.24	-0.22	-0.24	-0.39	-0.46	-0.30	-0.23	-0.25	-0.32
Leverage Ratio	1.66	1.59	1.63	1.63	1.57	1.60	1.67	1.72	1.73	1.67	1.58
Compound Leverage Factor	1.67	1.62	1.75	1.66	1.72	1.77	1.91	1.45	1.91	1.96	2.21
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	2.31%	2.44%	7.33%	7.35%	1.58%	1.86%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	5.54%	5.07%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	2.31%	2.44%	1.79%	2.28%	1.58%	1.86%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	97.69%	97.56%	92.67%	92.65%	98.42%	98.14%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.09	0.15	0.47	0.56	0.13	0.15
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	-1.90	-2.34	-1.25	-1.73	-2.09	-2.96
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.09	0.15	0.11	0.17	0.13	0.15
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.13	0.27	0.81	1.04	0.24	0.23
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	-2.83	-4.08	-2.17	-3.20	-3.80	-4.60
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.13	0.27	0.20	0.32	0.24	0.23
Altman Z-Score	11.23	12.23	11.40	10.41	7.54	7.49	5.55	5.17	4.56	4.94	6.47
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.80	4.11	2.86	3.11	3.47	3.53	2.86	2.69	2.64	2.89	3.38
Quick Ratio	3.31	3.60	2.51	2.72	3.09	3.20	2.50	2.42	2.45	2.54	2.82
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	53	22	12	61	55	204	-8.73	-10	19	6.77	98
Operating Cash Flow to CapEx	1,339.27%	801.24%	150.82%	1,861.19%	2,244.69%	5,340.87%	677.65%	-169.55%	823.05%	502.89%	2,537.51%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	9.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	5.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	1.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	3.02	3.10	3.09	2.93	2.60	2.34	2.10	2.26	2.21	2.15	2.30
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.08	6.00
Inventory Turnover	34.45	36.15	40.17	42.18	41.38	43.83	49.01	63.45	73.49	84.46	95.26
Fixed Asset Turnover	111.13	117.75	138.05	151.66	0.00	0.00	0.00	66.18	64.60	60.23	65.87
Accounts Payable Turnover	29.08	31.75	27.44	26.02	27.84	27.98	24.20	22.56	19.23	18.10	20.16
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	71.88	60.82
Days Inventory Outstanding (DIO)	10.60	10.10	9.09	8.65	8.82	8.33	7.45	5.75	4.97	4.32	3.83
Days Payable Outstanding (DPO)	12.55	11.50	13.30	14.03	13.11	13.04	15.08	16.18	18.98	20.17	18.11
Cash Conversion Cycle (CCC)	-1.96	-1.40	-4.21	-5.38	-4.29	-4.71	-7.64	-10.43	-14.02	56.04	46.54
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	194	247	317	338	342	227	279	330	345	372	316
Invested Capital Turnover	7.51	7.09	6.60	6.11	5.41	6.18	6.49	5.55	4.95	4.78	5.34
Increase / (Decrease) in Invested Capital	5.02	53	70	21	3.87	-115	51	51	15	27	-56
Enterprise Value (EV)	1,942	2,271	3,179	2,447	1,476	1,660	1,080	801	655	724	1,153
Market Capitalization	2,045	2,363	3,262	2,550	1,594	1,913	1,254	889	766	851	1,347
Book Value per Share	$4.12	$4.67	$5.46	$5.97	$6.21	$6.46	$6.07	$5.65	$6.18	$6.82	$7.24
Tangible Book Value per Share	$3.26	$3.86	$4.34	$4.92	$5.22	$5.53	$4.79	$4.41	$5.00	$5.66	$6.01
Total Capital	296	339	400	441	460	492	464	451	493	508	520
Total Debt	0.00	0.00	0.00	0.00	0.00	11	11	33	36	8.03	9.66
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	11	11	8.10	11	8.03	9.66
Net Debt	-103	-92	-83	-102	-118	-253	-174	-88	-111	-128	-194
Capital Expenditures (CapEx)	4.73	5.17	5.06	4.30	4.17	4.07	5.48	4.82	5.29	6.13	5.71
Debt-free, Cash-free Net Working Capital (DFCFNWC)	167	222	260	242	249	146	170	223	232	228	202
Debt-free Net Working Capital (DFNWC)	269	314	343	345	367	410	355	345	380	364	406
Net Working Capital (NWC)	269	314	343	345	367	410	355	320	355	364	406
Net Nonoperating Expense (NNE)	-0.46	-1.69	-6.03	-1.73	-5.48	-9.15	-5.97	6.47	-3.68	-5.90	-17
Net Nonoperating Obligations (NNO)	-103	-92	-83	-102	-118	-253	-174	-88	-111	-128	-194
Total Depreciation and Amortization (D&A)	8.34	9.22	10	11	15	16	17	18	16	16	17
Debt-free, Cash-free Net Working Capital to Revenue	11.59%	14.22%	14.00%	12.10%	13.53%	8.28%	10.36%	13.20%	13.90%	13.31%	11.00%
Debt-free Net Working Capital to Revenue	18.74%	20.08%	18.44%	17.21%	19.94%	23.30%	21.64%	20.39%	22.72%	21.22%	22.10%
Net Working Capital to Revenue	18.74%	20.08%	18.44%	17.21%	19.94%	23.30%	21.64%	18.91%	21.23%	21.22%	22.10%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.81	$1.06	$1.20	$1.13	$0.87	$1.32	$0.61	$0.47	$0.52	$0.54	$0.82
Adjusted Weighted Average Basic Shares Outstanding	71.83M	72.75M	73.36M	74.00M	74.36M	74.70M	74.82M	74.34M	74.29M	73.75M	72.38M
Adjusted Diluted Earnings per Share	$0.80	$1.05	$1.19	$1.12	$0.87	$1.32	$0.61	$0.47	$0.52	$0.53	$0.81
Adjusted Weighted Average Diluted Shares Outstanding	72.51M	73.47M	74.35M	74.61M	74.59M	74.79M	74.96M	74.35M	74.34M	73.99M	73.03M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	72.18M	72.81M	73.68M	74.04M	74.40M	74.72M	74.00M	74.39M	73.58M	73.49M	70.27M
Normalized Net Operating Profit after Tax (NOPAT)	58	76	82	82	59	90	43	41	35	34	42
Normalized NOPAT Margin	4.01%	4.84%	4.42%	4.08%	3.21%	5.09%	2.59%	2.41%	2.08%	1.96%	2.30%
Pre Tax Income Margin	6.25%	7.70%	7.14%	4.99%	4.62%	7.34%	3.99%	2.64%	3.17%	3.09%	3.69%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	90.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	60.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	87.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	56.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	88.54%	68.92%	62.62%	68.48%	91.28%	61.52%	128.19%	185.07%	0.00%	0.00%	0.00%
Augmented Payout Ratio	88.54%	68.92%	62.62%	68.82%	92.19%	62.20%	175.45%	188.20%	31.66%	15.32%	104.28%

This table displays calculated financial ratios and metrics derived from Healthcare Services Group's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	70,267,582.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	70,267,582.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	0.37
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.75%	-0.04%	1.49%	1.76%	4.07%	3.30%	5.72%	7.55%	8.45%	6.59%	3.37%
EBITDA Growth	-113.19%	52.76%	13.35%	-91.63%	2,635.48%	-45.45%	24.99%	-3,755.34%	143.84%	65.98%	39.60%
EBIT Growth	-356.56%	65.92%	18.96%	-131.09%	459.76%	-51.60%	30.63%	-1,498.24%	177.44%	87.79%	47.09%
NOPAT Growth	-653.84%	49.52%	18.27%	-128.83%	483.38%	-46.45%	31.13%	-1,498.24%	178.76%	155.23%	53.91%
Net Income Growth	-1,667.39%	49.05%	31.17%	-121.66%	377.99%	-49.29%	12.54%	-1,710.18%	206.15%	162.11%	51.27%
EPS Growth	0.00%	45.45%	31.25%	-118.18%	371.43%	-53.13%	9.52%	-2,100.00%	210.53%	186.67%	60.87%
Operating Cash Flow Growth	129.71%	115.98%	-59.81%	120.44%	46.67%	-26.78%	205.64%	76.40%	1,553.36%	-51.97%	59.01%
Free Cash Flow Firm Growth	43.38%	114.03%	68.10%	93.06%	91.05%	-400.56%	411.36%	1,035.29%	4,013.06%	638.21%	180.57%
Invested Capital Growth	10.11%	4.70%	6.33%	0.28%	4.17%	7.76%	-4.39%	-16.09%	-24.97%	-15.10%	-18.43%
Revenue Q/Q Growth	-1.80%	3.03%	-0.10%	0.67%	0.44%	2.26%	2.25%	2.42%	1.28%	0.50%	-0.84%
EBITDA Q/Q Growth	-106.02%	4,152.04%	-35.32%	-94.80%	1,724.91%	-12.82%	50.99%	-252.17%	221.74%	-40.66%	26.99%
EBIT Q/Q Growth	-149.42%	719.52%	-39.45%	-116.42%	671.81%	-16.65%	66.96%	-300.85%	199.26%	-43.58%	30.77%
NOPAT Q/Q Growth	-145.83%	744.13%	-40.24%	-116.00%	709.35%	-10.04%	49.51%	-294.99%	206.28%	-17.63%	-9.84%
Net Income Q/Q Growth	-161.15%	565.78%	-36.09%	-111.68%	884.68%	-15.04%	44.53%	-287.87%	232.71%	-27.26%	-16.59%
EPS Q/Q Growth	-163.64%	557.14%	-34.38%	-109.52%	1,050.00%	-21.05%	53.33%	-291.30%	234.09%	-27.12%	-13.95%
Operating Cash Flow Q/Q Growth	-60.29%	1,581.80%	-152.65%	162.69%	-73.58%	739.61%	-24.04%	4.68%	147.66%	-75.61%	151.51%
Free Cash Flow Firm Q/Q Growth	15.46%	113.81%	-292.16%	71.53%	-9.05%	-364.02%	316.11%	-14.47%	356.24%	-36.18%	12.66%
Invested Capital Q/Q Growth	-0.85%	-8.40%	14.53%	-3.59%	2.99%	-5.24%	1.62%	-15.39%	-7.91%	7.22%	-2.36%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	8.37%	17.63%	15.24%	9.75%	14.81%	13.39%	15.18%	0.65%	20.76%	15.44%	16.39%
EBITDA Margin	-0.20%	7.73%	5.10%	0.26%	4.79%	4.08%	6.03%	-8.96%	10.77%	6.36%	8.14%
Operating Margin	-1.12%	6.72%	4.16%	-0.68%	3.86%	3.15%	5.14%	-10.08%	9.88%	5.54%	7.31%
EBIT Margin	-1.12%	6.72%	4.16%	-0.68%	3.86%	3.15%	5.14%	-10.08%	9.88%	5.54%	7.31%
Profit (Net Income) Margin	-1.23%	5.55%	3.62%	-0.42%	3.28%	2.72%	3.85%	-7.06%	9.25%	6.69%	5.63%
Tax Burden Percent	79.69%	72.78%	71.83%	90.03%	74.60%	80.51%	72.10%	77.27%	74.95%	109.43%	75.45%
Interest Burden Percent	137.82%	113.46%	121.03%	68.70%	113.77%	107.45%	103.86%	90.66%	124.95%	110.35%	102.08%
Effective Tax Rate	0.00%	27.22%	28.17%	0.00%	25.40%	19.49%	27.90%	0.00%	25.05%	-9.43%	24.55%
Return on Invested Capital (ROIC)	-3.63%	24.20%	13.06%	-2.10%	12.73%	12.12%	16.66%	-35.65%	38.94%	32.39%	29.76%
ROIC Less NNEP Spread (ROIC-NNEP)	-1.10%	21.40%	9.45%	-2.39%	10.62%	11.43%	16.07%	-35.63%	33.17%	30.58%	29.45%
Return on Net Nonoperating Assets (RNNOA)	0.18%	-4.88%	-1.52%	0.42%	-1.83%	-2.85%	-3.49%	9.28%	-10.01%	-9.75%	-9.77%
Return on Equity (ROE)	-3.45%	19.31%	11.53%	-1.68%	10.90%	9.26%	13.17%	-26.37%	28.93%	22.65%	19.98%
Cash Return on Invested Capital (CROIC)	-1.87%	5.69%	3.42%	6.87%	7.16%	1.89%	14.20%	18.90%	36.31%	28.61%	35.25%
Operating Return on Assets (OROA)	-2.54%	14.85%	9.16%	-1.46%	8.44%	6.78%	10.99%	-22.30%	22.19%	12.76%	16.54%
Return on Assets (ROA)	-2.78%	12.27%	7.96%	-0.91%	7.17%	5.86%	8.23%	-15.62%	20.78%	15.40%	12.74%
Return on Common Equity (ROCE)	-3.45%	19.31%	11.53%	-1.68%	10.90%	9.26%	13.17%	-26.37%	28.93%	22.65%	19.98%
Return on Equity Simple (ROE_SIMPLE)	6.94%	0.00%	8.86%	6.78%	10.45%	0.00%	8.05%	2.27%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-3.22	21	13	-2.02	12	11	17	-32	34	28	26
NOPAT Margin	-0.78%	4.89%	2.99%	-0.47%	2.88%	2.53%	3.71%	-7.05%	7.40%	6.07%	5.52%
Net Nonoperating Expense Percent (NNEP)	-2.54%	2.80%	3.60%	0.29%	2.11%	0.69%	0.60%	-0.02%	5.77%	1.82%	0.31%
Return On Investment Capital (ROIC_SIMPLE)	-	4.20%	-	-	-	2.18%	3.18%	-6.68%	6.84%	5.45%	4.88%
Cost of Revenue to Revenue	91.63%	82.37%	84.76%	90.25%	85.19%	86.61%	84.82%	99.35%	79.24%	84.56%	83.61%
SG&A Expenses to Revenue	9.49%	10.91%	11.08%	10.42%	10.95%	10.24%	10.04%	10.72%	10.88%	9.90%	9.08%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	9.49%	10.91%	11.08%	10.42%	10.95%	10.24%	10.04%	10.72%	10.88%	9.90%	9.08%
Earnings before Interest and Taxes (EBIT)	-4.60	28	18	-2.89	17	14	23	-46	46	26	34
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-0.81	33	22	1.12	21	18	27	-41	50	30	38
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.75	1.68	1.94	1.65	1.68	1.70	1.44	2.30	2.46	2.64	2.54
Price to Tangible Book Value (P/TBV)	2.19	2.08	2.38	2.02	2.03	2.05	1.75	2.82	2.98	3.18	3.05
Price to Revenue (P/Rev)	0.46	0.46	0.55	0.46	0.48	0.50	0.43	0.62	0.67	0.73	0.70
Price to Earnings (P/E)	32.02	19.14	21.88	23.98	14.82	21.83	17.74	91.43	30.83	22.11	18.93
Dividend Yield	8.17%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	3.12%	5.23%	4.57%	4.17%	6.75%	4.58%	5.64%	1.09%	3.24%	4.52%	5.28%
Enterprise Value to Invested Capital (EV/IC)	1.88	1.90	2.13	1.81	1.84	1.94	1.60	2.93	3.45	3.65	3.56
Enterprise Value to Revenue (EV/Rev)	0.42	0.39	0.50	0.41	0.43	0.42	0.35	0.53	0.56	0.63	0.59
Enterprise Value to EBITDA (EV/EBITDA)	13.35	10.15	12.58	12.60	9.52	11.84	9.09	38.63	18.91	17.57	14.39
Enterprise Value to EBIT (EV/EBIT)	19.34	13.64	16.59	17.86	12.12	16.07	11.99	132.06	27.92	23.75	18.50
Enterprise Value to NOPAT (EV/NOPAT)	25.42	18.86	22.99	25.29	16.72	21.55	16.09	190.77	38.02	27.29	21.39
Enterprise Value to Operating Cash Flow (EV/OCF)	41.85	15.05	24.96	16.15	16.43	23.49	7.17	9.70	6.21	7.95	6.81
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	34.06	64.29	26.33	26.25	106.81	11.01	14.16	8.15	11.71	9.07
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.13	0.08	0.11	0.09	0.07	0.02	0.02	0.01	0.01	0.02	0.02
Long-Term Debt to Equity	0.03	0.02	0.02	0.02	0.02	0.02	0.02	0.01	0.01	0.02	0.02
Financial Leverage	-0.17	-0.23	-0.16	-0.17	-0.17	-0.25	-0.22	-0.26	-0.30	-0.32	-0.33
Leverage Ratio	1.71	1.73	1.66	1.69	1.67	1.67	1.65	1.69	1.64	1.58	1.59
Compound Leverage Factor	2.35	1.96	2.01	1.16	1.90	1.79	1.71	1.53	2.04	1.74	1.63
Debt to Total Capital	11.37%	7.35%	9.63%	7.94%	6.51%	1.58%	1.52%	1.46%	1.24%	1.86%	1.79%
Short-Term Debt to Total Capital	9.03%	5.07%	7.62%	5.86%	4.78%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	2.34%	2.28%	2.02%	2.08%	1.73%	1.58%	1.52%	1.46%	1.24%	1.86%	1.79%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	88.63%	92.65%	90.37%	92.06%	93.49%	98.42%	98.48%	98.54%	98.76%	98.14%	98.21%
Debt to EBITDA	1.07	0.56	0.76	0.74	0.45	0.13	0.12	0.29	0.12	0.15	0.12
Net Debt to EBITDA	-1.22	-1.73	-1.18	-1.65	-1.26	-2.09	-2.04	-6.46	-3.74	-2.96	-2.69
Long-Term Debt to EBITDA	0.22	0.17	0.16	0.19	0.12	0.13	0.12	0.29	0.12	0.15	0.12
Debt to NOPAT	2.03	1.04	1.38	1.49	0.79	0.24	0.21	1.43	0.23	0.23	0.18
Net Debt to NOPAT	-2.32	-3.20	-2.16	-3.30	-2.22	-3.80	-3.62	-31.90	-7.52	-4.60	-4.00
Long-Term Debt to NOPAT	0.42	0.32	0.29	0.39	0.21	0.24	0.21	1.43	0.23	0.23	0.18
Altman Z-Score	4.58	4.47	4.74	4.41	4.67	4.82	4.61	4.88	5.82	6.38	6.14
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.84	2.64	2.77	2.74	2.93	2.89	2.89	2.49	2.97	3.38	3.11
Quick Ratio	2.60	2.45	2.45	2.41	2.59	2.54	2.52	2.14	2.51	2.82	2.62
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-38	5.23	-11	-3.10	-3.38	-16	34	29	132	85	95
Operating Cash Flow to CapEx	159.78%	3,450.45%	-1,198.02%	1,374.81%	317.99%	2,569.48%	1,601.69%	2,199.16%	5,376.55%	1,277.52%	3,256.14%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	2.27	2.21	2.20	2.16	2.19	2.15	2.14	2.21	2.25	2.30	2.26
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	5.08	0.00	0.00	0.00	6.00	5.81
Inventory Turnover	70.40	73.49	75.94	77.69	80.45	84.46	85.42	89.69	92.41	95.26	96.79
Fixed Asset Turnover	62.62	64.60	63.80	59.36	59.11	60.23	59.49	61.05	65.33	65.87	65.75
Accounts Payable Turnover	21.37	19.23	21.17	21.32	19.80	18.10	19.89	21.04	19.99	20.16	19.83
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	71.88	0.00	0.00	0.00	60.82	62.80
Days Inventory Outstanding (DIO)	5.18	4.97	4.81	4.70	4.54	4.32	4.27	4.07	3.95	3.83	3.77
Days Payable Outstanding (DPO)	17.08	18.98	17.24	17.12	18.43	20.17	18.35	17.35	18.26	18.11	18.41
Cash Conversion Cycle (CCC)	-11.90	-14.02	-12.43	-12.42	-13.90	56.04	-14.08	-13.28	-14.31	46.54	48.16
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	377	345	396	381	393	372	378	320	295	316	309
Invested Capital Turnover	4.65	4.95	4.37	4.42	4.42	4.78	4.50	5.05	5.26	5.34	5.39
Increase / (Decrease) in Invested Capital	35	15	24	1.08	16	27	-17	-61	-98	-56	-70
Enterprise Value (EV)	709	655	843	689	724	724	605	939	1,017	1,153	1,098
Market Capitalization	774	766	922	779	820	851	741	1,096	1,219	1,347	1,303
Book Value per Share	$5.95	$6.18	$6.42	$6.40	$6.66	$6.82	$7.00	$6.54	$6.85	$7.24	$7.31
Tangible Book Value per Share	$4.76	$5.00	$5.24	$5.23	$5.49	$5.66	$5.77	$5.33	$5.64	$6.01	$6.09
Total Capital	498	493	525	512	523	508	522	484	502	520	523
Total Debt	57	36	51	41	34	8.03	7.95	7.05	6.22	9.66	9.36
Total Long-Term Debt	12	11	11	11	9.03	8.03	7.95	7.05	6.22	9.66	9.36
Net Debt	-65	-111	-79	-90	-96	-128	-136	-157	-201	-194	-205
Capital Expenditures (CapEx)	1.84	1.43	2.17	1.19	1.36	1.41	1.72	1.31	1.33	1.36	1.34
Debt-free, Cash-free Net Working Capital (DFCFNWC)	269	232	281	263	276	228	232	154	177	202	193
Debt-free Net Working Capital (DFNWC)	391	380	411	394	406	364	376	318	385	406	408
Net Working Capital (NWC)	346	355	371	364	381	364	376	318	385	406	408
Net Nonoperating Expense (NNE)	1.83	-2.79	-2.66	-0.24	-1.70	-0.83	-0.64	0.02	-8.58	-2.93	-0.53
Net Nonoperating Obligations (NNO)	-65	-111	-79	-90	-96	-128	-136	-157	-201	-194	-205
Total Depreciation and Amortization (D&A)	3.79	4.31	3.99	4.02	3.98	4.10	4.00	5.12	4.15	3.81	3.85
Debt-free, Cash-free Net Working Capital to Revenue	16.11%	13.90%	16.78%	15.61%	16.21%	13.31%	13.35%	8.71%	9.81%	11.00%	10.43%
Debt-free Net Working Capital to Revenue	23.37%	22.72%	24.50%	23.37%	23.85%	21.22%	21.62%	17.97%	21.29%	22.10%	22.02%
Net Working Capital to Revenue	20.67%	21.23%	22.12%	21.59%	22.38%	21.22%	21.62%	17.97%	21.29%	22.10%	22.02%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.07)	$0.32	$0.21	($0.02)	$0.19	$0.16	$0.23	($0.44)	$0.59	$0.44	$0.37
Adjusted Weighted Average Basic Shares Outstanding	74.36M	74.29M	73.93M	73.85M	73.69M	73.75M	73.67M	73.16M	72.24M	72.38M	69.86M
Adjusted Diluted Earnings per Share	($0.07)	$0.32	$0.21	($0.02)	$0.19	$0.15	$0.23	($0.44)	$0.59	$0.43	$0.37
Adjusted Weighted Average Diluted Shares Outstanding	74.36M	74.34M	74.06M	73.85M	73.93M	73.99M	73.96M	73.16M	72.97M	73.03M	71.05M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	73.85M	73.58M	73.65M	73.38M	73.29M	73.49M	72.92M	72.41M	70.46M	70.27M	68.65M
Normalized Net Operating Profit after Tax (NOPAT)	-3.22	21	13	-2.02	12	11	17	-32	34	18	26
Normalized NOPAT Margin	-0.78%	4.89%	2.99%	-0.47%	2.88%	2.53%	3.71%	-7.05%	7.40%	3.88%	5.52%
Pre Tax Income Margin	-1.54%	7.62%	5.03%	-0.47%	4.39%	3.38%	5.34%	-9.14%	12.34%	6.12%	7.46%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	23.19%	31.66%	24.01%	40.93%	19.75%	15.32%	33.34%	170.86%	112.59%	104.28%	119.21%

Financials Breakdown Chart

Key Financial Trends

Here are notable trends for Healthcare Services Group (HCSG) based on the last four years of quarterly data, focusing on revenue, profitability, cash flow, and balance-sheet momentum.

Long-run revenue uptrend: Total revenue rose from roughly $424M in 2022 to about $467M in 2025 (Q4), indicating a positive top-line trend over the period.
Strong, recent quarterly profitability in 2025: Net income attributable to common shareholders reached $31.5M in Q4 2025, up from about $10.1M in Q4 2024, showing meaningful year-over-year improvement in profitability.
Material cash on hand improving liquidity: Cash & equivalents jumped from about $11.9M at end-2024 to around $124.4M by 2025-Q3, signaling markedly stronger liquidity late in the period.
Rising equity base: Total equity grew from roughly $477M at end-2024 to about $496M by 2025-Q3, reflecting an expanding capital base.

Earnings per share recovery in 2025: Diluted EPS was $0.59 in Q3 2025, higher than earlier 2025 quarters (e.g., negative or lower prints in Q2 2025), suggesting a rebound in earnings power during the year.
Balanced asset base with stable size: Total assets hovered around $800M, increasing modestly from about $722M at some mid-2023 points to roughly $804M by 2025, indicating a relatively stable asset base with gradual growth.
Seasonality and cash flow variability in operating cash flow: Net cash from continuing operating activities fluctuated across 2025 (e.g., about $71.3M in Q3 2025, but lower in other quarters), implying seasonal or quarterly timing effects on cash generation.

Earnings volatility within the year: After a strong Q3 2025, Q2 2025 showed a negative Consolidated Net Income, underscoring quarterly earnings swings and heightened volatility in profitability.
Operating cash flow can dip quarter-to-quarter: Q4 2025 saw a notable drop in net cash from continuing operating activities relative to Q3 2025, which may indicate cadence risk in cash generation.
Profitability margins not always expanding: While some quarters show rising net income, margin history is inconsistent (e.g., net income as a percentage of revenue varies across 2022–2025), suggesting margin pressure in parts of the cycle.

05/11/26 10:14 AM ETAI Generated. May Contain Errors.

Healthcare Services Group Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Healthcare Services Group's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Healthcare Services Group's net income appears to be on a downward trend, with a most recent value of $59.06 million in 2025, rising from $58.02 million in 2015. The previous period was $39.47 million in 2024. See where experts think Healthcare Services Group is headed by visiting Healthcare Services Group's forecast page.

Healthcare Services Group's total operating income in 2025 was $48.54 million, based on the following breakdown:

Total Gross Profit: $239.41 million
Total Operating Expenses: $190.87 million

Over the last 10 years, Healthcare Services Group's total revenue changed from $1.44 billion in 2015 to $1.84 billion in 2025, a change of 27.9%.

Healthcare Services Group's total liabilities were at $284.04 million at the end of 2025, a 6.2% decrease from 2024, and a 54.0% increase since 2015.

In the past 10 years, Healthcare Services Group's cash and equivalents has ranged from $9.56 million in 2017 to $139.33 million in 2020, and is currently $125.19 million as of their latest financial filing in 2025.

Over the last 10 years, Healthcare Services Group's book value per share changed from 4.12 in 2015 to 7.24 in 2025, a change of 75.8%.

Related Companies

Financial statements for NASDAQ:HCSG last updated on 4/27/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Healthcare Services Group (HCSG) Financials

Financials Breakdown Chart

Key Financial Trends

Healthcare Services Group Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Healthcare Services Group (HCSG) Financials

Annual Income Statements for Healthcare Services Group

Quarterly Income Statements for Healthcare Services Group

Annual Cash Flow Statements for Healthcare Services Group

Quarterly Cash Flow Statements for Healthcare Services Group

Annual Balance Sheets for Healthcare Services Group

Quarterly Balance Sheets for Healthcare Services Group

Annual Metrics And Ratios for Healthcare Services Group

Quarterly Metrics And Ratios for Healthcare Services Group

Financials Breakdown Chart

Key Financial Trends

Healthcare Services Group Financials - Frequently Asked Questions

When does Healthcare Services Group's financial year end?

How has Healthcare Services Group's net income changed over the last 10 years?

What is Healthcare Services Group's operating income?

How has Healthcare Services Group's revenue changed over the last 10 years?

How much debt does Healthcare Services Group have?

How much cash does Healthcare Services Group have?

How has Healthcare Services Group's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools